Get started
Author

Ilenia Di Cola

Observed names: Di Cola, Ilenia, I. DI Cola, I. Di Cola
ORCID: 0000-0001-7489-3137
Observed ORCID: 0000-0001-7489-3137
OpenAlex ID: A5085007757
Beyond the joints, the extra-articular manifestations in rheumatoid arthritis
2020 · Alessandro Conforti, Ilenia Di Cola, et al. · Autoimmunity Reviews · 407
Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence–radiological differences
2020 · Piero Ruscitti, Federico Bruno, et al. · Annals of the Rheumatic Diseases · 46
PDF
Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still’s disease
2022 · Piero Ruscitti, Valentina Natoli, et al. · Lara D. Veeken · 41
PDF
Expanding the spectrum of the hyperferritinemic syndrome, from pathogenic mechanisms to clinical observations, and therapeutic implications
2022 · Piero Ruscitti, Ilenia Di Cola, et al. · Autoimmunity Reviews · 40
Spectrum of short-term inflammatory musculoskeletal manifestations after COVID-19 vaccine administration: a report of 66 cases
2021 · Francesco Ursini, Piero Ruscitti, et al. · Annals of the Rheumatic Diseases · 40
PDF
Inflammatory rheumatic diseases with onset after SARS-CoV-2 infection or COVID-19 vaccination: a report of 267 cases from the COVID-19 and ASD group
2023 · Francesco Ursini, Piero Ruscitti, et al. · RMD Open · 35
Cytokine profile, ferritin and multi-visceral involvement characterize macrophage activation syndrome during adult-onset Still’s disease
2022 · Piero Ruscitti, Francesco Ursini, et al. · Lara D. Veeken · 34
Efficacy and safety of tocilizumab in adult-onset Still's disease: Real-life experience from the international AIDA registry
2022 · Jurgen Sota, Antonio Vitale, et al. · Seminars in Arthritis and Rheumatism · 32
Development and Implementation of the AIDA International Registry for Patients With Still's Disease
2022 · Antonio Vitale, Francesca Della Casa, et al. · Frontiers in Medicine · 31
PDF
Still’s disease continuum from childhood to elderly: data from the international AIDA Network Still’s disease registry
2023 · Antonio Vitale, Valeria Caggiano, et al. · RMD Open · 30
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus
2024 · Piero Ruscitti, Yannick Allanore, et al. · Autoimmunity Reviews · 29
PDF
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry
2023 · Piero Ruscitti, Francesco Masedu, et al. · RMD Open · 28
Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome
2022 · Antonio Vitale, Valeria Caggiano, et al. · Frontiers in Medicine · 27
PDF
The Pathogenic Role of Interferons in the Hyperinflammatory Response on Adult-Onset Still’s Disease and Macrophage Activation Syndrome: Paving the Way towards New Therapeutic Targets
2021 · Ilenia Di Cola, Piero Ruscitti, et al. · Journal of Clinical Medicine · 27
PDF
Cytokine profile characterization of naïve patients with psoriasis and psoriatic arthritis: implications for a pathogenic disease continuum
2023 · Piero Ruscitti, Maria Esposito, et al. · Frontiers in Immunology · 22
PDF
Nail and enthesis assessment in patients with psoriatic disease by high frequency ultrasonography: findings from a single-centre cross-sectional study
2022 · Piero Ruscitti, Maria Esposito, et al. · La radiologia medica · 22
PDF
The Autoinflammatory Diseases Alliance Registry of monogenic autoinflammatory diseases
2022 · Carla Gaggiano, Antonio Vitale, et al. · Frontiers in Medicine · 21
PDF
Efficacy of canakinumab in patients with Still’s disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for Still’s Disease
2023 · Antonio Vitale, Valeria Caggiano, et al. · Frontiers in Medicine · 19
PDF
The Systemic Score May Identify Life‐Threatening Evolution in Still Disease: Data from the GIRRCS AOSD‐Study Group and the AIDA Network Still Disease Registry
2024 · Piero Ruscitti, Francesco Masedu, et al. · Arthritis & Rheumatology · 17
The effects of suppressing inflammation by tofacitinib may simultaneously improve glycaemic parameters and inflammatory markers in rheumatoid arthritis patients with comorbid type 2 diabetes: a proof-of-concept, open, prospective, clinical study
2024 · Claudia Di Muzio, Ilenia Di Cola, et al. · Arthritis Research & Therapy · 16
PDF
Adult-onset Still's disease with elderly onset, results from a multicentre study
2021 · Ilenia Di Cola, Claudia Di Muzio, et al. · Clinical and Experimental Rheumatology · 16
PDF
Systemic syndromes of rheumatological interest with onset after COVID-19 vaccine administration: a report of 30 cases
2022 · Francesco Ursini, Piero Ruscitti, et al. · Clinical Rheumatology · 14
PDF
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments
2021 · Clodoveo Ferri, Dilia Giuggioli, et al. · Current Pharmaceutical Design · 14
PDF
Impact of smoking habit on adult-onset Still’s disease prognosis, findings from a multicentre observational study
2021 · Piero Ruscitti, Ilenia Di Cola, et al. · Clinical Rheumatology · 13
Incidence of venous thromboembolism in rheumatoid arthritis, results from a “real-life” cohort and an appraisal of available literature
2021 · Alessandro Conforti, Onorina Berardicurti, et al. · Medicine · 13
Works count: 80
Citation count: 1,259
H-index: 18
I10-index: 35
Year
Topic
Type